Literature DB >> 16541404

An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites.

F Musshoff1, J Trafkowski, U Kuepper, B Madea.   

Abstract

A fully validated liquid chromatographic procedure coupled with electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) is presented for quantitative determination of the opioids buprenorphine, codeine, fentanyl, hydromorphone, methadone, morphine, oxycodone, oxymorphone, piritramide, tilidine, and tramadol together with their metabolites bisnortilidine, morphine-glucuronides, norfentanyl, and nortilidine in blood plasma after an automatically performed solid-phase extraction (SPE). Separation was achieved in 35 min on a Phenomenex C12 MAX-RP column (4 microm, 150 x 2 mm) using a gradient of ammonium formiate buffer (pH 3.5) and acetonitrile. The validation data were within the required limits. The assay was successfully applied to authentic plasma samples, allowing confirmation of the diagnosis of overdose situations as well as monitoring of patients' compliance, especially in patients under palliative care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541404     DOI: 10.1002/jms.1021

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  10 in total

1.  Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.

Authors:  Tomoya Sakurada; Shinya Takada; Hisae Eguchi; Keishiro Izumi; Nobunori Satoh; Shiro Ueda
Journal:  Pharm World Sci       Date:  2010-08-21

2.  Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Nina Sophia Mahlke; Victoria Ziesenitz; Gerd Mikus; Gisela Skopp
Journal:  Int J Legal Med       Date:  2014-07-06       Impact factor: 2.686

3.  Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.

Authors:  Marta Concheiro; Hendreé Jones; Rolley E Johnson; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-01-01       Impact factor: 3.205

4.  The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.

Authors:  Stacy S Shord; Larisa H Cavallari; Weihua Gao; Hyun-Young Jeong; Kelly Deyo; Shitalben R Patel; Joseph R Camp; Susan M Labott; Robert E Molokie
Journal:  Eur J Clin Pharmacol       Date:  2009-04-09       Impact factor: 2.953

5.  Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.

Authors:  Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2009-04-29       Impact factor: 2.395

6.  Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

Authors:  Marta Concheiro-Guisan; Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-02-27       Impact factor: 4.142

7.  A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats.

Authors:  Nageswara R Pilli; Suresh Narayanasamy; Lin Xu; Ashok Chockalingam; Katherine I Shea; Sharron Stewart; Rodney Rouse; Vikram Patel; Murali K Matta
Journal:  RSC Adv       Date:  2020-01-03       Impact factor: 4.036

8.  Simultaneous Quantification of Opioids in Blood and Urine by Gas Chromatography-Mass Spectrometer with Modified Dispersive Solid-Phase Extraction Technique.

Authors:  Sara Yasien; Ejaz Ali; Mohsin Javed; Muhammad Muntazir Iqbal; Shahid Iqbal; Hamad Alrbyawi; Samar O Aljazzar; Eslam B Elkaeed; Ayed A Dera; Rami Adel Pashameah; Eman Alzahrani; Abd-ElAziem Farouk
Journal:  Molecules       Date:  2022-10-10       Impact factor: 4.927

9.  CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.

Authors:  Ulrike M Stamer; Lan Zhang; Malte Book; Lutz E Lehmann; Frank Stuber; Frank Musshoff
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  The Quantification of Oxycodone and Its Phase I and II Metabolites in Urine.

Authors:  Michael T Truver; Gerd Jakobsson; Maria D Chermà; Madeleine J Swortwood; Henrik Gréen; Robert Kronstrand
Journal:  J Anal Toxicol       Date:  2022-02-14       Impact factor: 3.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.